Corey Fyfe

Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens

Joyce A. Sutcliffe, William J. O’Brien, Corey Fyfe et al. · Antimicrobial Agents and Chemotherapy · 2013 · 231 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic

Trudy H. Grossman, Agata L. Starosta, Corey Fyfe et al. · Antimicrobial Agents and Chemotherapy · 2012 · 163 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent

Xiao-Yi Xiao, Diana K. Hunt, Jingye Zhou et al. · Journal of Medicinal Chemistry · 2011 · 125 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

<i>In Vitro</i> Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Ian Morrissey, Melanie Olesky, Stephen Hawser et al. · Antimicrobial Agents and Chemotherapy · 2019 · 97 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy

Roger B. Clark, Diana K. Hunt, Minsheng He et al. · Journal of Medicinal Chemistry · 2011 · 72 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16